FDA Drugs (New Approvals & NDA)Original article
Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations - 10/14/2026
ConferenceNeutral
AI Analysis
Summary
An FDA-hosted event dated 10/14/2026 covers the Bayesian draft guidance, addressing design, analysis, and review considerations for clinical trials. It targets clinical trial, regulatory science, and regulatory affairs professionals.
Importance:2/10
Sentiment:
0.00
FDABayesiandraft guidanceclinical trial designregulatory scienceevent
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 18, 2026 12:49 PM